Last reviewed · How we verify

NCT06799182: PD and CRC

Periodontal Disease and Colorectal Cancer

Completed NA Last updated 29 January 2025
What this trial tests

NA trial testing periodontal treatment in Periodontal Diseases in 20 participants. Completed in 5 November 2024.

Timeline
25 October 2023
Primary endpoint
30 September 2024
5 November 2024

Quick facts

Lead sponsorUniversity Medical Centre Ljubljana
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date25 October 2023
Primary completion30 September 2024
Estimated completion5 November 2024
Sites1 location across Slovenia

Drugs / interventions tested

Conditions studied

Sponsor

University Medical Centre Ljubljana

Who can join

18 and older, any sex, with Periodontal Diseases or Colorectal Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this interventional study is to determine the impact of periodontal disease and periodontal treatment on patients with colorectal cancer. The main questions were: 1. Does periodontal treatment affect the levels of C-reactive protein in the blood of patients undergoing cancer treatment? 2. Can the investigators isolate periodontal pathogenic bacteria Fusobacterium nucleatum and Porphyromonas gingivalis from the mucosa of cancerous colon tissue using the method of quantitative culture? The investigators will compare the levels of C-reactive protein in the blood of patients undergoing treatment for colorectal cancer who have received periodontal treatment with patients who have not received periodontal treatment. CRP levels will be measured during the first examination with the oncological surgeon, on the first and second day after the surgical procedure, and during the first follow-up with the oncological surgeon. Additionally, the investigators collected samples of cancerous colon mucosa from 10 participants for the attempt to isolate F. nucleatum and P. gingivalis using the quantitative culture method.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The influence of periodontal disease and periodontal treatment on colorectal cancer.
    Rebersak UP, Brecelj E, Schara R. · · 2025 · PMID 40272186 · DOI 10.2478/raon-2025-0025

Verify or expand the search:

Other trials of periodontal treatment

Trials testing the same drug.

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other University Medical Centre Ljubljana trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06799182.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing